News 6/18/25
Top News
Ambient scribe technology vendor Nabla raises $70 million in a Series C funding round, increasing its total to $120 million.
The company will use the money to develop an agentic AI platform that will…
Top News
Ambient scribe technology vendor Nabla raises $70 million in a Series C funding round, increasing its total to $120 million.
The company will use the money to develop an agentic AI platform that will…
A new study from South Korea has demonstrated the use of AI models to possibly diagnose and stratify attention deficit hyperactivity disorder by analysing eye images.FINDINGS
Researchers from Yonsei University Health System have used four…
Explore how a leading provider of neurodevelopmental healthcare services revolutionized its referral process by integrating scientifically validated tools for ADHD and ASD into its established business systems. This case study highlights the significant advancements…
Continue ReadingAttention-deficit/hyperactivity disorder (ADHD), characterized by diagnostic complexity and symptom heterogeneity, is a prevalent neurodevelopmental disorder. Here, we explored the machine learning (ML) analysis of retinal fundus photographs as a noninvasive biomarker for ADHD screening…
Continue ReadingBirmingham Community Healthcare NHS Foundation Trust is piloting the CLEO SOLO electronic prescribing solution (EPS) in its children’s services.
The two-year pilot is planned to launch in March 2025 in community paediatrics and the ADHD…
A project to support young people with attention deficit and hyperactivity disorder (ADHD) has secured funding to develop a multilingual virtual assistant.
A collaboration between the Digital Futures Lab at Torbay and South Devon NHS…
In this blog, Chandanee Mistry, UK Lead at Braingaze, shares insights into the launch of BGaze Focus, a self-help app designed to help reduce symptoms of ADHD. The app is designed to transform how…
Continue ReadingBackground: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in school-aged children. The lack of objective biomarkers for ADHD often results in missed diagnoses or misdiagnoses, which lead to inappropriate or delayed interventions. Eye-tracking…
Continue ReadingWhat You Should Know:
– Cerebral, Inc., an online mental healthcare provider, has entered into a non-prosecution agreement (NPA) with the U.S. Attorney’s Office for the Eastern District of New York to pay more than…
Continue ReadingMedavie Blue Cross (MBC) announced an enhanced version of its digital health and wellness platform Connected Care, which includes access to its partnership with Beyond ADHD.Beyond ADHD uses an evidence-based, multi-modal approach to treatment…
Continue Reading